JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Journal of Clinical Pathology 2005;58:1096-1100; doi:10.1136/jcp.2004.025072
Copyright © 2005 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bais, A G
Right arrow Articles by Helmerhorst, T J M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bais, A G
Right arrow Articles by Helmerhorst, T J M
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Cervical Cancer

ORIGINAL ARTICLE

A shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesions

A G Bais1, I Beckmann1, J Lindemans2, P C Ewing3, C J L M Meijer4, P J F Snijders4, T J M Helmerhorst1

1 Department of Obstetrics and Gynaecology, Erasmus University Medical Centre, PO Box 2040, 3000 CA Rotterdam, The Netherlands
2 Department of Clinical Chemistry, Erasmus University Medical Centre
3 Department of Pathology, Erasmus University Medical Centre
4 Department of Pathology, Vrije Universiteit Medical Centre, PO Box 7057, 1007 MB Amsterdam, The Netherlands

Correspondence to:
Professor T J M Helmerhorst
Department of Obstetrics and Gynaecology, Erasmus University Medical Centre Rotterdam, PO Box 2040, 3000 CA, Rotterdam, The Netherlands; t.helmerhorst{at}erasmusmc.nl Background: A shifted balance between T helper 1 (Th1)-type and Th2-type cytokines has been hypothesised in cervical dysplasia

Aims: To evaluate possible deregulation of the cytokine network by estimating the expression of peripheral cytokines in different stages of cervical disease and in relation to the presence or absence of high risk human papillomavirus (HR-HPV).

Methods: Twenty one HR-HPV positive women with high grade cervical intraepithelial neoplasia (CIN II–III) and 12 patients with invasive cervical carcinoma formed the study groups. Two control groups consisted of 10 HR-HPV positive and 11 HR-HPV negative women without CIN. Differences in leucocyte subgroups were evaluated by a differential leucocyte count. Plasma concentrations of tumour necrosis factor {alpha} (TNF{alpha}), TNF{alpha} receptors TNFRI and TNFRII, interferon {gamma} (IFN{gamma}), interleukin 2 (IL-2), IL-12, IL-4, and IL-10 were determined by enzyme linked immunosorbent assays.

Results: Leucocyte counts in patients with CIN III and carcinoma were significantly higher than in controls. Plasma IFN{gamma} concentrations were significantly lower in patients with CIN III and carcinoma than in women with CIN II or controls. Plasma concentrations of IL-12, IL-2, IL-4, and TNF{alpha} did not differ significantly between groups, but significantly lower plasma concentrations of TNFRII were found in CIN III and carcinoma compared with CIN II. IL-10 was detected with increased frequency in the plasma of patients with CIN III and carcinoma.

Conclusions: These results indicate that a shift to a Th2-type cytokine pattern during the carcinogenesis of cervical cancer occurs in women with CIN III lesions.


Abbreviations: CIN, cervical intraepithelial neoplasia; CV, coefficient of variation; HPV, human papillomavirus; HR, high risk; IFN{gamma}, interferon {gamma}; IL, interleukin; MDC, minimal detectable concentration; PCR, polymerase chain reaction; s, soluble; Th, T helper; TNF{alpha}, tumour necrosis factor {alpha}; TNFR, tumour necrosis factor {alpha} receptor

Keywords: cervical dysplasia; peripheral cytokines; high risk human papillomavirus




This article has been cited by other articles:


Home page
Hum Mol GenetHome page
V. B. Guzman, A. Yambartsev, A. Goncalves-Primo, I. D.C.G. Silva, C. R.N. Carvalho, J. C.L. Ribalta, L. R. Goulart, N. Shulzhenko, M. Gerbase-DeLima, and A. Morgun
New approach reveals CD28 and IFNG gene interaction in the susceptibility to cervical cancer
Hum. Mol. Genet., June 15, 2008; 17(12): 1838 - 1844.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2005 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.